Gasporox AB

As of March 31, 2026, Gasporox AB carries a market capitalization of 69.03M, placing it among publicly traded companies globally. Its enterprise value stands at 56.19M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Gasporox AB's next confirmed earnings release is scheduled for October 22, 2026.

As of March 31, 2026, Gasporox AB has 9.35M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 2.23, and the price-to-book ratio stands at 3.79.

These figures are as of March 31, 2026. The EV/Sales ratio of 1.82 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 56.19M versus a market cap of 69.03M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Gasporox AB maintains a current ratio of 1.67, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended March 31, 2026, Gasporox AB posted a negative return on equity (ROE) of -40.22, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -20.67, reflecting losses generated across the asset base. The company generates approximately 1.47M in revenue per employee across its workforce of 21.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.13 indicates how many times Gasporox AB sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, Gasporox AB's stock has declined approximately 30.03% over the past 52 weeks. The 50-day moving average sits at 6.18, while the 200-day moving average is 7.05.

Over the twelve months ended March 31, 2026, Gasporox AB generated 30.92M in revenue and converted that into -9.03M in net income, yielding earnings per share of -0.97. EBITDA reached -831,000.00, while operating income came in at -7.31M.

These figures are as of March 31, 2026. Total book value stands at 18.24M, with working capital of 9.33M providing operational flexibility.

Gasporox AB produced 3.44M in operating cash flow over the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, Gasporox AB posted a gross margin of 97.75, reflecting its pricing power and cost economics. The operating margin of -23.64 and net profit margin of -29.22 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield stands at 4.98, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -17.72, meaning Gasporox AB raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Gasporox AB's most recent stock split took place on May 24, 2018 with a 151:155 split ratio.